JCI vs TLSIW
Johnson Controls International PLC (JCI) versus TriSalus Life Sciences Inc. (TLSIW) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
TriSalus Life Sciences Inc. (TLSIW) common stock listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
TLSIW does not have a complete income-statement cache yet.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. TLSIW currently screens at market cap $0.
Not investment advice. Open the JCI and TLSIW stock pages for the full models.
Not investment advice.